• 2025.08.07 Investor Relations

  Annual Report 2025

  
• 2025.07.31 Investor Relations

  Financial Results Announcement FYE2026/3 (FY2025) Q1

  
• 2025.06.09 Investor Relations

  Financial Results Briefing FYE2025/3 (FY2024)

  
• 2025.06.06 Investor Relations

  Notice of the 101st Annual General Meeting of Shareholders

  
• 2025.05.15 Investor Relations

  Medium-Term Management Plan (FY2025-2027)

  
• 2025.05.15 Investor Relations

  Notice Concerning Continuation of Performance-Linked Stock-Based Allocation System for Management-Level Employees of the Company

  
• 2025.05.15 Investor Relations

  Notice Concerning Continuation and Partial Amendments to Performance-Linked Stock-Based Remuneration System

  
• 2025.05.15 Investor Relations

  Notice Regarding Partial Amendments to the Articles of Incorporation

  
• 2025.05.15 Investor Relations

  Notice Regarding Variances Between Forecasts and Actual Full-Year Consolidated Results and Dividends of Surplus for the Fiscal Year Ended March31,2025

  
• 2025.05.15 Investor Relations

  Consolidated Financial Results for the Year Ended March 31, 2025 [Japanese GAAP]

  
• 2025.01.31 Investor Relations

  Consolidated Financial Results for the Nine Months Ended December 31, 2024 [Japanese GAAP]

  

• 2025.08.07 Investor Relations

  Annual Report 2025

  
• 2025.07.31 Investor Relations

  Financial Results Announcement FYE2026/3 (FY2025) Q1

  
• 2025.06.09 Investor Relations

  Financial Results Briefing FYE2025/3 (FY2024)

  
• 2025.06.06 Investor Relations

  Notice of the 101st Annual General Meeting of Shareholders

  
• 2025.05.15 Investor Relations

  Medium-Term Management Plan (FY2025-2027)

  
• 2025.05.15 Investor Relations

  Notice Concerning Continuation of Performance-Linked Stock-Based Allocation System for Management-Level Employees of the Company

  
• 2025.05.15 Investor Relations

  Notice Concerning Continuation and Partial Amendments to Performance-Linked Stock-Based Remuneration System

  
• 2025.05.15 Investor Relations

  Notice Regarding Partial Amendments to the Articles of Incorporation

  
• 2025.05.15 Investor Relations

  Notice Regarding Variances Between Forecasts and Actual Full-Year Consolidated Results and Dividends of Surplus for the Fiscal Year Ended March31,2025

  
• 2025.05.15 Investor Relations

  Consolidated Financial Results for the Year Ended March 31, 2025 [Japanese GAAP]

  
• 2025.01.31 Investor Relations

  Consolidated Financial Results for the Nine Months Ended December 31, 2024 [Japanese GAAP]